Does CAPECITABINE Cause Malignant neoplasm progression? 2,425 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,425 reports of Malignant neoplasm progression have been filed in association with CAPECITABINE (Capecitabine). This represents 3.8% of all adverse event reports for CAPECITABINE.
2,425
Reports of Malignant neoplasm progression with CAPECITABINE
3.8%
of all CAPECITABINE reports
461
Deaths
403
Hospitalizations
How Dangerous Is Malignant neoplasm progression From CAPECITABINE?
Of the 2,425 reports, 461 (19.0%) resulted in death, 403 (16.6%) required hospitalization, and 54 (2.2%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPECITABINE. However, 2,425 reports have been filed with the FAERS database.
What Other Side Effects Does CAPECITABINE Cause?
Diarrhoea (9,277)
Nausea (6,248)
Palmar-plantar erythrodysaesthesia syndrome (5,294)
Fatigue (5,018)
Death (4,422)
Vomiting (4,111)
Disease progression (3,808)
Off label use (3,193)
Asthenia (2,352)
Decreased appetite (2,275)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which CAPECITABINE Alternatives Have Lower Malignant neoplasm progression Risk?
CAPECITABINE vs CAPIVASERTIB
CAPECITABINE vs CAPLACIZUMAB
CAPECITABINE vs CAPLACIZUMAB-YHDP
CAPECITABINE vs CAPMATINIB
CAPECITABINE vs CAPREOMYCIN